Remodeling of the ischemia-reperfused murine heart: 11.7-T cardiac magnetic resonance imaging of contrast-enhanced infarct patches and transmurality

Antioxidants and Redox Signaling

Volumn 11, Issue 8, 2009, Pages 1829-1839

  Gnyawali, Surya C ^a   Roy, Sashwati ^a   McCoy, Molly ^a   Biswas, Sabyasachi ^a   Sen, Chandan K ^a  

^a Laboratory of Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REMODELING; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; REPERFUSION INJURY;

ANIMALS; CONTRAST MEDIA; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED BALB C; MYOCARDIAL ISCHEMIA;

MURINAE;

EID: 67650263718     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2635     Document Type: Article

References (50)

1. Barbier CE, Bjerner T, Johansson L, Lind L, and Ahlstrom H. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol 48: 765-771, 2006.
2. Barrabes JA, Figueras J, Cortadellas J, Lidon RM, and Ibars S. Usefulness of electrocardiographic and echocardiographic left ventricular hypertrophy to predict adverse events in patients with a first non-ST-elevation acute myocardial infarction. Am J Cardiol 103: 455-460, 2009.
3. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM, Gheor- ghiade M, and Kim RJ. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta- blocker therapy. Circulation 108: 1945-1953, 2003.
4. Bondarenko O, Beek AM, Twisk JW, Visser CA, and van Rossum AC. Time course of functional recovery after re- vascularization of hibernating myocardium: a contrast- enhanced cardiovascular magnetic resonance study. Eur Heart J 29: 2000-2005, 2008.
5. Bundschuh CV, Stein L, Slusser JH, Schinco FP, Ladaga LE, and Dillon JD. Distinguishing between scar and recurrent herniated disk in postoperative patients: value of contrast- enhanced CT and MR imaging. AJNR Am J Neuroradiol 11:949-958, 1990.
6. Catalano O, Antonaci S, Moro G, Cannizzaro G, Mingrone R, Opasich C, Frascaroli M, Rognone F, Baldi M, and Tra- marin R. Contrast-enhanced magnetic resonance imaging assessment of scar size in patients with chronic myocardial infarction. Ital Heart J 6: 133-137, 2005.
7. Chan J, Khafagi F, Young AA, Cowan BR, Thompson C, and Marwick TH. Impact of coronary revascularization and transmural extent of scar on regional left ventricular remodelling. Eur Heart J 29: 1608-1617, 2008.
8. Chapon C, Herlihy AH, and Bhakoo KK. Assessment of myocardial infarction in mice by late gadolinium enhancement MR imaging using an inversion recovery pulse sequence at 9.4T. J Cardiovasc Magn Reson 10: 6, 2008.
9. Choi BW. Differentiation of acute myocardial infarction from chronic myocardial scar with MRI. Korean J Radiol 7:1-3,2006.
10. Egred M, Al-Mohammad A, Waiter GD, Redpath TW, Semple SK, Norton M, Welch A, and Walton S. Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI. Heart 89: 738-744, 2003.
11. Feigenbaum H. Feigenbaum's echocardiography. 6th ed. New York: Lippincott Williams and Wilkins, 2005.
12. Gilson WD, Epstein FH, Yang Z, Xu Y, Prasad KM, Toufektsian MC, Laubach VE, and French BA. Border zone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide syn-thase knockout mice. JAm Coll Cardiol 50: 1799-1807, 2007.
13. Gilson WD and Kraitchman DL. Cardiac magnetic resonance imaging in small rodents using clinical 1.5 T and 3.0 T scanners. Methods 43: 35-45, 2007.
14. Haughton V, Schreibman K, and De Smet A. Contrast between scar and recurrent herniated disk on contrast-enhanced MR images. AJNR Am JNeuroradiol 23: 1652-1656, 2002.
15. Heiberg E, Engblom H, Engvall J, Hedstrom E, Ugander M, and Arheden H. Semi-automatic quantification of myocar- dial infarction from delayed contrast enhanced magnetic resonance imaging. Scand Cardiovasc J 39: 267-275, 2005.
16. Helm PA, Caravan P, French BA, Jacques V, Shen L, Xu Y, Beyers RJ, Roy RJ, Kramer CM, and Epstein FH. Post- infarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology 247: 788-796, 2008.
17. Hendrikx M, Hensen K, Clijsters C, Jongen H, Koninckx R, Bijnens E, Ingels M, Jacobs A, Geukens R, Dendale P, Vijgen J, Dilling D, Steels P, Mees U, and Rummens JL. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 114: I101-107, 2006.
18. Hunold P, Schlosser T, Vogt FM, Eggebrecht H, Schmer- mund A, Bruder O, Schuler WO, and Barkhausen J. Myo- cardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 184: 1420-1426, 2005.
19. Isbell DC and Kramer CM. Cardiovascular magnetic resonance: structure, function, perfusion, and viability. J Nucl Cardiol 12: 324-336, 2005.
20. Judd RM, Wagner A, Rehwald WG, Albert T, and Kim RJ. Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging. Nat Clin Pract Cardiovasc Med 2: 150-158, 2005.
21. Kaandorp TA, Lamb HJ, Viergever EP, Poldermans D, Boersma E, van der Wall EE, de Roos A, and Bax JJ. Scar tissue on contrast-enhanced MRI predicts left ventricular remodelling after acute infarction. Heart 93: 375-376, 2007.
22. Kan G, Visser CA, Koolen JJ, and Dunning AJ. Short and long term predictive value of admission wall motion score in acute myocardial infarction: a cross sectional echocardio- graphic study of 345 patients. Br Heart J 56: 422-27, 1986.
23. Kim KA, Seo JB, Do KH, Heo JN, Lee YK, Song JW, Lee JS, Song KS, and Lim TH. Differentiation of recently infarcted myocardium from chronic myocardial scar: the value of contrast-enhanced SSFP-based cine MR imaging. Korean J Radiol 7: 14-19, 2006.
24. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, and Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100: 1992-2002, 1999.
25. Kuhn DE, Roy S, Radtke J, Gupta S, and Sen CK. Laser microdissection and pressure-catapulting technique to study gene expression in the reoxygenated myocardium. Am J Physiol Heart Circ Physiol 290: H2625-H2632, 2006.
26. Kuhn DE, Roy S, Radtke J, Khanna S, and Sen CK. Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyperoxia induces p21 in peri-infarct myocytes. Am J Physiol Heart Circ Physiol 292: H1245-H1253, 2007.
27. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, and Davis RB. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113: 2733-2743, 2006.
28. Kwong RY and Korlakunta H. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Top Magn Reson Imaging 19: 15-24, 2008.
29. McNamara MT and Higgins CB. Magnetic resonance imaging of chronic myocardial infarcts in man. AJR Am J Roentgenol 146: 315-320, 1986.
30. McNamara MT, Higgins CB, Schechtmann N, Botvinick E, Lipton MJ, Chatterjee K, and Amparo EG. Detection and characterization of acute myocardial infarction in man with use of gated magnetic resonance. Circulation 71:717-724,1985.
31. Nieman K, Shapiro MD, Ferencik M, Nomura CH, Abbara S, Hoffmann U, Gold HK, Jang IK, Brady TJ, and Cury RC. Reperfused myocardial infarction: contrast-enhanced 64- section CT in comparison to MR imaging. Radiology 247: 49-56, 2008.
32. Oh YS, Thomson LE, Fishbein MC, Berman DS, Sharifi B, and Chen PS. Scar formation after ischemic myocardial injury in MRL mice. Cardiovasc Pathol 13: 203-206, 2004.
33. Ojha N, Roy S, Radtke J, Simonetti O, Gnyawali S, Zweier JL, Kuppusamy P, and Sen CK. Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 294: H2435-H2443, 2008.
34. Orn S, Manhenke C, Anand IS, Squire I, Nagel E, Edvardsen T, and Dickstein K. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. Am J Cardiol 99: 1109-1114, 2007.
35. Raman SV, Richards DR, Jekic M, Dickerson JA, Kander NH, Foster EL, and Simonetti OP. Treadmill stress cardiac magnetic resonance imaging: first in vivo demonstration of exercise-induced apical ballooning. J Am Coll Cardiol 52:1884, 2008.
36. Raman SV, Simonetti OP, Cataland SR, and Kraut EH. Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease. Haematologica 91:1329-1335, 2006.
37. Reimer KA and Jennings RB. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs. Circulation 71: 1069-1075, 1985.
38. Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, and Sen CK. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phospha- tase and tensin homologue. Cardiovasc Res 82: 21-29, 2009.
39. Roy S, Khanna S, Rink T, Radtke J, Williams WT, Biswas S, Schnitt R, Strauch AR, and Sen CK. P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibro-blasts. Mol Biol Cell 18: 4837-4846, 2007.
40. Saraste A, Nekolla S, and Schwaiger M. Contrast-enhanced magnetic resonance imaging in the assessment of myocar- dial infarction and viability. J Nucl Cardiol 15: 105-117, 2008.
41. Schvartzman PR, Srichai MB, Grimm RA, Obuchowski NA, Hammer DF, McCarthy PM, Kasper JM, and White RD. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction. Am Heart J 146: 535-541, 2003.
42. Simonetti OP, Finn JP, White RD, Laub G, and Henry DA. ''Black blood'' T2-weighted inversion-recovery MR imaging of the heart. Radiology 199: 49-57, 1996.
43. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, and Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218: 215-223, 2001.
44. Strzelczyk J and Attili A. Cardiac magnetic resonance evaluation of myocardial viability and ischemia. Semin Roent-genol 43: 193-203, 2008.
45. Tanabe K, Ishibashi Y, Shimada T, Tsukihashi H, Hatano J, Oyake N, Morioka S, Moriyama K, Sugimura K, Yuasa K, and Kawamitsu H. Evaluating coronary reperfusion during acute myocardial infarction in a canine model by gadolinium- DTPA-enhanced magnetic resonance imaging. Jpn Circ J 57:458-466, 1993.
46. van Deel ED, Lu Z, Xu X, Zhu G, Hu X, Oury TD, Bache RJ, Duncker DJ, and Chen Y. Extracellular superoxide dis- mutase protects the heart against oxidative stress and hypertrophy after myocardial infarction. Free Radic Biol Med 44:1305-1313, 2008.
47. Wang YN, Jin ZY, Zhang ZH, Kong LY, Chen LB, Zhou L, Sun HY, Zhang H, and Miao Q. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging and comparison with single-photon emission computed tomography. Chin Med Sci J 21: 239-244, 2006.
48. Wiesmann F, Ruff J, Engelhardt S, Hein L, Dienesch C, Leupold A, Illinger R, Frydrychowicz A, Hiller KH, Rommel E, Haase A, Lohse MJ, and Neubauer S. Dobutamine-stress magnetic resonance microimaging in mice: acute changes of cardiac geometry and function in normal and failing murine hearts. Circ Res 88: 563-569, 2001.
49. Yang Z, Berr SS, Gilson WD, Toufektsian MC, and French BA. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation 109: 1161-1167, 2004.
50. Zhou R, Pickup S, Glickson JD, Scott CH, and Ferrari VA. Assessment of global and regional myocardial function in the mouse using cine and tagged MRI. Magn Reson Med 49:760-764, 2003.